Product Overview
Azacitidine API is one of the antineoplastic (anti-cancer) agents available for the treatment of certain blood and bone marrow disorders.
The product belongs to the class of nucleoside metabolic inhibitors and begins to work by inhibiting DNA methylation.
In this manner, the product helps to restore the normal functioning of genes and thereby controls cell growth.
Azacitidine is, however, available in both injectable and lyophilised powder form.
Therapeutic Applications
Azacitidine API is mainly prescribed for the treatment of Myelodysplastic Syndromes, where it helps to improve the blood cell production.
Helps to control Acute Myeloid Leukaemia, and for those who do not react significantly to intensive chemotherapy.
Another condition treated is Chronic Myelomonocytic Leukaemia, where Azacitidine controls the proliferation of abnormal white cells.
Enhances the regeneration of healthy bone marrow cells.
Specification Parameters
The generic name is Azacitidine
Dosage available is Lyophilised Powder / Injection
The temperature is between 2°C and 8°C
Shell-life is typically 24 months.
-
Chemical Name: 4-Amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one
-
Molecular Formula: C₈H₁₂N₄O₅
-
Molecular Weight: 244.21 g/mol
-
CAS Number: 320-67-2
Packaging & Storage
Azacitidine must be packed in sterile, single-use glass vials that maintain product integrity and stability.
The packaging ensures protection from moisture, light, and contamination.
It is advisable not to freeze it and keep it in its original packaging.
Why Choose Us
We are the trusted supplier of Azacitidine API and ensure the top-quality product.
With our global export expertise, we export Azacitidine across different regions and with proper documentation.
Our products are cost-effective in this manner, and the purchase becomes easier.
We also provide dedicated customer support to upgrade our customers’ knowledge completely.
